Hologic Announces Financial Results for First Quarter of Fiscal 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Hologic (HOLX) Tops Q1 EPS by 69c, Revenues Beat; Offers 2Q EPS/Revenue Guidance Above Consensus
January 27, 2021 4:06 PM ESTHologic (NASDAQ: HOLX) reported Q1 EPS of $2.86, $0.69 better than the analyst estimate of $2.17. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.4 billion.
Revenue of $1.61 Billion Increases 89.3%, 86.5% in Constant Currency Organic Revenue Increases 107.0%, 104.0% in Constant Currency Company Posts GAAP Diluted EPS of $2.50, Non-GAAP Diluted EPS of $2.86Hologic had a strong start to fiscal 2021 across... More
